Fexmid Oral Tablet 7.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Fexmid: Oral tablet (7.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_9582.JPG
Fexmid 7.5mg Tab
Shionogi USA, Inc.
Pill Identification: WATSON  |  3330
Drug Image file DrugItem_14429.JPG
Fexmid 7.5mg Tab
Shionogi USA, Inc.
Pill Identification: WATSON  |  3330
Drug Image file DrugItem_16072.JPG
Fexmid 7.5mg Tab
Shionogi Pharma, Inc.
Pill Identification: WATSON  |  3330

What is this Medicine?

CYCLOBENZAPRINE (sye kloe BEN za preen) is a muscle relaxer. It is used to treat muscle pain, spasms, and stiffness.

In-Depth Information
Select a Medication

Fexmid 7.5mg Tablet

NDC: 684530950
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Muscle Spasm

Sometimes used for but not FDA approved for the following conditions:
Fibromyalgia

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Fexmid 7.5mg Tablet
Drug Image file DrugItem_9582.JPG
Shionogi USA, Inc.
Pill Identification: WATSON  |  3330
Shape: round
Color: white
Drug Image file DrugItem_14429.JPG
Shionogi USA, Inc.
Pill Identification: WATSON  |  3330
Shape: round
Color: white

Reported Side Effects for Fexmid 7.5mg Tablet

Diaphoresis Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Incoordination Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<6.0%*
Severity: MODERATE
Onset: EARLY
Feeling Sick Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Excessive Mucle Tone Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Excitability Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Peripheral Vasodilation Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Dysarthria Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Double Vision Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Retaining Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Shaking Incidence:
<6.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
1.0-8.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Confusion Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
1.0-17.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
1.0-6.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
3.0-19.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
6.0-58.0%*
Severity: MILD
Onset: EARLY
Acne Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
16.0-39.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Fexmid 7.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Fexmid 7.5mg Tablet(Cyclobenzaprine Hydrochloride)
Alcohol and Cyclobenzaprine Hydrochloride(Cyclobenzaprine Hydrochloride)
In general, it is recommended that you avoid Alcoholic drinks while you are taking Cyclobenzaprine. Taking Cyclobenazprine with Alcohol can increase drowsiness, and the risk of side effects. Decreased alertness, drowsiness, falls, or other side effects may occur. Do not drive or operate machinery if you are drinking alcohol-containing beverages, or while taking Cyclobenzaprine until you know how it affects you.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fexmid

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5